Published in BMC Cancer on December 26, 2002
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol (2009) 15.23
ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst (2009) 4.72
Is breast cancer the same disease in Asian and Western countries? World J Surg (2010) 2.33
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res (2010) 1.82
Hepatitis B virus-induced oncogenesis. World J Gastroenterol (2007) 1.82
Spectrum of breast cancer in Asian women. World J Surg (2007) 1.79
SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer (2008) 1.70
Protons make tumor cells move like clockwork. Pflugers Arch (2009) 1.48
Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax (2006) 1.40
NELSON lung cancer screening study. Cancer Imaging (2011) 1.37
Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site. BMC Cancer (2002) 1.31
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. J Biol Chem (2010) 1.27
Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma. World J Gastroenterol (2011) 1.17
Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev (2010) 1.11
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br J Cancer (2005) 1.07
Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis. PLoS One (2012) 1.07
The suitability of using death certificates as a data source for cancer mortality assessment in Turkey. Croat Med J (2012) 1.07
The role of surgery after incomplete endoscopic mucosal resection for early gastric cancer. Surg Today (2007) 1.05
Fluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patients. PLoS One (2013) 1.05
Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Investig (2007) 1.05
Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2009) 1.04
Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale. Trop Med Int Health (2011) 1.04
Breast Self-examination: Knowledge, Attitude, and Practice among Female Dental Students in Hyderabad City, India. Indian J Palliat Care (2012) 1.03
New combination therapies with cell-cycle agents. Curr Opin Investig Drugs (2008) 0.98
Is Surgical Treatment Necessary after Non-curative Endoscopic Resection for Early Gastric Cancer? J Gastric Cancer (2010) 0.97
A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer. BMC Cancer (2008) 0.95
Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy. J Cancer Res Clin Oncol (2011) 0.93
Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J Gastroenterol (2010) 0.93
Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16- and 64-row multi-detector CT: an anthropomorphic phantom study. Eur Radiol (2012) 0.92
Incidence of breast cancer in fars province, southern iran: a hospital-based study. World J Plast Surg (2012) 0.92
IL-11 is a parietal cell cytokine that induces atrophic gastritis. Gut (2011) 0.92
In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction. BMC Cancer (2010) 0.92
Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Res (2010) 0.91
Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis. Oral Oncol (2013) 0.90
The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients. Diagn Pathol (2013) 0.89
Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway. BMC Cancer (2014) 0.88
Cancer vaccines: on the threshold of success. Expert Opin Emerg Drugs (2008) 0.87
Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes (2008) 0.86
Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers. J Cancer Res Clin Oncol (2010) 0.85
Effects of depression on parameters of cell-mediated immunity in patients with digestive tract cancers. World J Gastroenterol (2004) 0.85
Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway. Oncol Rep (2012) 0.85
Mortality patterns in the West Bank, Palestinian Territories, 1999-2003. Prev Chronic Dis (2008) 0.83
Clinical efficacy of neoadjuvant chemotherapy with platinum-based regimen for patients with locoregionally advanced head and neck squamous cell carcinoma: an evidence-based meta-analysis. Ann Saudi Med (2011) 0.83
A phase II clinical trial of ZD1839 (Iressa) in combination with docetaxel as first-line treatment in patients with advanced breast cancer. Invest New Drugs (2007) 0.83
Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells. Exp Ther Med (2012) 0.82
Salt and stress synergize H. pylori-induced gastric lesions, cell proliferation, and p21 expression in Mongolian gerbils. Dig Dis Sci (2007) 0.82
Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One (2012) 0.82
DNA Methylation mediated down-regulating of MicroRNA-33b and its role in gastric cancer. Sci Rep (2016) 0.82
Increased sMICA and TGFβ1 levels in HNSCC patients impair NKG2D-dependent functionality of activated NK cells. Oncoimmunology (2015) 0.81
Long-term follow-up of non-calcified pulmonary nodules (<10 mm) identified during low-dose CT screening for lung cancer. Eur Radiol (2012) 0.81
Chemoradiotherapy is superior to radiotherapy alone after surgery in advanced squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Int J Clin Exp Med (2014) 0.81
Genetic Factors Are Not the Major Causes of Chronic Diseases. PLoS One (2016) 0.81
Tubulin α-6 chain is a stably expressed reference gene in archival samples of normal oral tissue and oral squamous cell carcinoma. Exp Ther Med (2010) 0.81
Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front. PLoS One (2013) 0.80
Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays. Toxicol Pathol (2009) 0.80
Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis. Cost Eff Resour Alloc (2010) 0.80
Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids. Front Immunol (2015) 0.80
Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers. ScientificWorldJournal (2013) 0.79
Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model. Oncotarget (2015) 0.79
Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review. Oncologist (2010) 0.79
Inherent phenotypic plasticity facilitates progression of head and neck cancer: endotheliod characteristics enable angiogenesis and invasion. Exp Cell Res (2013) 0.79
A novel platform for electromagnetic navigated ultrasound bronchoscopy (EBUS). Int J Comput Assist Radiol Surg (2015) 0.79
Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers. World J Gastroenterol (2005) 0.79
Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population. DNA Cell Biol (2011) 0.79
Lack of association between human papillomavirus infection and colorectal cancer. Prz Gastroenterol (2014) 0.78
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer. Br J Cancer (2006) 0.78
Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway. Int J Nanomedicine (2014) 0.78
CD200: association with cancer stem cell features and response to chemoradiation in head and neck squamous cell carcinoma. Head Neck (2014) 0.78
PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1(+) and CD8(+) tumor-infiltrating T cells and outcome. Mod Pathol (2016) 0.77
Harnessing information and communication technologies to leverage scarce resources for cancer education, research and practice in developing countries. Health Res Policy Syst (2006) 0.77
Predicting skeletal complications in metastatic breast cancer raises challenges. Breast Cancer Res Treat (2010) 0.77
Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells. Cancer Sci (2013) 0.77
Phytochemicals: a multitargeted approach to gynecologic cancer therapy. Biomed Res Int (2014) 0.77
Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein. World J Gastroenterol (2008) 0.77
Clinical implication of serosal change in pathologic subserosa-limited gastric cancer. World J Surg (2012) 0.77
The effect of radiation therapy on the mechanical and morphological properties of the enamel and dentin of deciduous teeth--an in vitro study. Radiat Oncol (2014) 0.77
MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer. J Carcinog (2009) 0.76
Colorectal carcinoma in different age groups : a histopathological analysis. Int J Colorectal Dis (2011) 0.76
Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma. Br J Cancer (2013) 0.76
High concordance of ALK rearrangement between primary tumor and paired metastatic lymph node in patients with lung adenocarcinoma. J Thorac Dis (2016) 0.75
The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC). PLoS One (2016) 0.75
Endoscopically diagnosed gastric cancers: looking alike, but behave differently. Clin Endosc (2013) 0.75
Genomic Copy Number Variations Characterize the Prognosis of Both P16-Positive and P16-Negative Oropharyngeal Squamous Cell Carcinoma After Curative Resection. Medicine (Baltimore) (2015) 0.75
Comparative Brain and Central Nervous System Tumor Incidence and Survival between the United States and Taiwan Based on Population-Based Registry. Front Public Health (2016) 0.75
New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer. Lung Cancer (Auckl) (2014) 0.75
Cancer burden in China from 2006 to 2010. Int J Clin Exp Pathol (2015) 0.75
Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma. BMC Oral Health (2015) 0.75
Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma. ISRN Surg (2012) 0.75
Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma. Front Immunol (2017) 0.75
A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa. Int J Womens Health (2017) 0.75
Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget (2017) 0.75
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer (1999) 8.61
Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer (1999) 6.11
Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ (2000) 3.95
Cancer deaths in India: is the model-based approach valid? Bull World Health Organ (1994) 1.46
Cancer in Mali, 1987-1988. Int J Cancer (1990) 1.41
Population-based cancer survival in Singapore, 1968 to 1992: an overview. Int J Cancer (2001) 1.33
Global and regional estimates of cancer mortality and incidence by site: I. Application of regional cancer survival model to estimate cancer mortality distribution by site. BMC Cancer (2002) 1.31
Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand (2002) 1.28
The global burden of cancer. Semin Cancer Biol (1998) 1.23
Global variations in cancer survival. Study Group on Cancer Survival in Developing Countries. Cancer (1996) 1.19
Quality of life in breast and colon cancer long-term survivors: an assessment with the EORTC QLQ-C30 and SF-36 questionnaires. Tumori (2002) 1.11
Quality of life in patients with early and advanced carcinoma of the breast. Eur J Surg Oncol (2000) 1.02
Trends in survival rates of cancer in Cuba. Eur J Epidemiol (1999) 0.99
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Household catastrophic health expenditure: a multicountry analysis. Lancet (2003) 20.07
WHO estimates of the causes of death in children. Lancet (2005) 18.33
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ (2005) 15.50
Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16
Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet (2009) 13.41
Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet (2010) 12.28
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Public financing of health in developing countries: a cross-national systematic analysis. Lancet (2010) 11.22
Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 10.52
Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet (2006) 9.85
Epidemiology and etiology of childhood pneumonia. Bull World Health Organ (2008) 9.17
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
The burden and costs of chronic diseases in low-income and middle-income countries. Lancet (2007) 8.33
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2011) 7.79
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70
Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet (2011) 7.63
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62
Global patterns of mortality in young people: a systematic analysis of population health data. Lancet (2009) 7.05
Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis (2002) 6.73
Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015. Lancet (2007) 6.72
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet (2005) 6.63
Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med (2006) 6.11
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med (2013) 6.04
Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol (2009) 6.02
Measuring the global burden of disease. N Engl J Med (2013) 5.84
Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet (2006) 5.70
Civil registration systems and vital statistics: successes and missed opportunities. Lancet (2007) 5.67
Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet (2010) 5.36
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis (2007) 4.87
Gaps in policy-relevant information on burden of disease in children: a systematic review. Lancet (2005) 4.64
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Monitoring global health: time for new solutions. BMJ (2004) 4.39
Validation of the symptom pattern method for analyzing verbal autopsy data. PLoS Med (2007) 4.35
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol (2005) 4.20
Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ (2005) 4.17
Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil (2011) 4.06
Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes. BMJ (2004) 3.94
A systematic analysis of global anemia burden from 1990 to 2010. Blood (2013) 3.94
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet (2010) 3.89
The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States. PLoS Med (2008) 3.73
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (2013) 3.65
Global mortality associated with rotavirus disease among children in 2004. J Infect Dis (2009) 3.63
Validity of verbal autopsy procedures for determining cause of death in Tanzania. Trop Med Int Health (2006) 3.62
Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol (2008) 3.61
Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59
Role of smoking in global and regional cardiovascular mortality. Circulation (2005) 3.57
Statistical modeling and projections of lung cancer mortality in 4 industrialized countries. Int J Cancer (2005) 3.53
Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health (2012) 3.44
WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ (2003) 3.42
Adult mortality: time for a reappraisal. Int J Epidemiol (2004) 3.41
Assessment of population-level effect of Avahan, an HIV-prevention initiative in India. Lancet (2011) 3.39
Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet (2006) 3.33
Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med (2011) 3.32
Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr (2005) 3.31
Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics. Bull World Health Organ (2005) 3.30
The way forward. Lancet (2007) 3.28
Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr (2011) 3.21
Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12